Parents of the youngest kids anxiously await approval of a Covid vaccine. CP3 Director Dr. Walid Gellad spoke with The New York Times about how regulators might weigh their decisions. "[Gellad] said he expected regulators would be especially careful in considering higher doses for young children given the comparatively low risks of them catching Covid now and getting severely ill," wrote Sharon LaFraniere and Noah Weiland, the article's authors.